home All News open_in_new Full Article

Un traitement révolutionnaire contre la leucémie mis au point à Montréal en 2014 est approuvé en Europe... mais pas au Canada

La Commission européenne a approuvé le mois dernier la thérapie cellulaire UM171 mise au point à Montréal, mais les patients d’ici devront attendre.


today 8 d. ago attach_file Economics

attach_file Sport
attach_file Other
attach_file Other
attach_file Transport
attach_file Economics
attach_file Politics
attach_file Politics
attach_file Other
attach_file Other
attach_file Other
attach_file Events
attach_file Other
attach_file Other
attach_file Society
attach_file Other
attach_file Other
attach_file Culture
attach_file Culture
attach_file Other
attach_file Other


ID: 643382591
Add Watch Country

arrow_drop_down